Reyes Financial Architecture’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
IA
VCM
VAM
Reyes Financial Architecture's AZN Position: Q1 2026 in Review
Reyes Financial Architecture sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 51 shares — an estimated $9.29K sold.
Reyes Financial Architecture first reported a position in AZN in Q4 2025 and held it in 1 quarter. The position peaked at $9.29K in Q4 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Reyes Financial Architecture reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
- Reyes Financial Architecture sold 51 AstraZeneca shares in Q1 2026, an estimated $9.29K.
- Reyes Financial Architecture first reported a position in AstraZeneca in Q4 2025 and held it in 1 quarter.
- Reyes Financial Architecture's AstraZeneca position peaked at $9.29K in Q4 2025.
- 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Reyes Financial Architecture's 13F filing for Q1 2026, filed 12 May 2026.